Colorectal Unit, Department of Surgery, Royal Adelaide Hospital, Adelaide, SA, 5000, Australia.
Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, 5000, Australia.
Int J Colorectal Dis. 2023 Jun 2;38(1):159. doi: 10.1007/s00384-023-04441-6.
Sarcopenia is a prognostic factor for poor outcomes in colorectal cancer, but data are scarce in colorectal surgery for benign conditions where patients could benefit from a deferral of surgery to enter a prehabilitation programme. We assessed the incidence of sarcopenia and complications in patients with benign colorectal disease.
Patients who underwent elective non-malignant colorectal surgery during 2018-2022 were retrospectively identified. The cross-sectional psoas area was calculated using computed tomography (CT) imaging mid-3 lumbar vertebrae. Sarcopenia was determined using gender-specific cut-offs. The primary outcome was complications measured by the comprehensive complication index (CCI).
Of 188 patients identified, 39 (20.7%) were sarcopenic. Patients diagnosed with sarcopenia were older (63 vs. 58 years, p = 0.047) and had a reduced BMI (24.7 vs. 27.38 kg/m, p = 0.001). Sarcopenic patients had more complications (82.1 vs. 64.4%, p = 0.036), and CCI was statistically but not clinically higher (20.9 vs. 20.9, p = 0.047). On univariate linear regression analysis, age ≥ 65 years old, ASA grade ≥ 3, active smokers, sarcopenia, and preoperative anaemia were predictive of CCI. Propensity score-matched analysis was performed, matching 78 cases to remove selection bias, which demonstrated sarcopenia had no impact on postoperative complications. On multivariate analysis, age (p = 0.022), smoking (p = 0.005), and preoperative anaemia (p = 0.008) remained predictive of CCI.
Sarcopenia is prevalent in one-fifth of patients undergoing benign colorectal surgery. Taking advantage of the longer preoperative waiting periods, sarcopenia could be explored as a target for prehabilitation programmes to improve outcomes.
肌少症是结直肠癌不良预后的一个预测因素,但在结直肠良性疾病的外科治疗中,数据较为缺乏,患者可能受益于推迟手术,进入康复前计划。我们评估了良性结直肠疾病患者的肌少症发生率和并发症。
回顾性分析 2018 年至 2022 年期间接受择期非恶性结直肠手术的患者。使用计算机断层扫描(CT)成像腰椎 3 中部计算横突肌的横截面积。使用性别特异性截断值确定肌少症。主要结局是使用综合并发症指数(CCI)测量的并发症。
在确定的 188 名患者中,有 39 名(20.7%)患有肌少症。诊断为肌少症的患者年龄更大(63 岁比 58 岁,p=0.047),体重指数更低(24.7 比 27.38kg/m,p=0.001)。肌少症患者的并发症更多(82.1%比 64.4%,p=0.036),CCI 在统计学上但不是临床上更高(20.9 比 20.9,p=0.047)。在单因素线性回归分析中,年龄≥65 岁、ASA 分级≥3、吸烟、肌少症和术前贫血是 CCI 的预测因素。进行了倾向评分匹配分析,匹配了 78 例病例以消除选择偏倚,结果表明肌少症对术后并发症没有影响。多因素分析显示,年龄(p=0.022)、吸烟(p=0.005)和术前贫血(p=0.008)仍然是 CCI 的预测因素。
肌少症在接受良性结直肠手术的患者中占五分之一。利用较长的术前等待期,可以探索肌少症作为康复前计划的目标,以改善结局。